Central Precocious Puberty in a 14-Month-Old Infant Girl With Vaginal Bleeding

Yılmaz Kör; Mehmet Keskin; Mesut Parlak; Özlem Keskin; Elif Güler; Ayşe Balat

doi:10.58600/eurjther.2010-16-2-1281-arch

Authors

Yılmaz Kör Gaziantep Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları AD
Mehmet Keskin Gaziantep Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları AD
Mesut Parlak Gaziantep Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları AD
Özlem Keskin Gaziantep Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları AD
Elif Güler Gaziantep Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları AD
Ayşe Balat Gaziantep Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları AD https://orcid.org/0000-0002-8904-1348

DOI:

https://doi.org/10.58600/eurjther.2010-16-2-1281-arch

Keywords:

Central precocious pubery, Vaginal bleeding, Idiopathic, Leuprorelin

Abstract

Precocious puberty is defined as the onset of secondary sexual characteristics before 8 year of age in girls. The first sign is generally development of the breast related with early activation of hypothalamic- pituitary-gonadal axis. Although central precocious puberty is mostly idiopathic the cause may be hypothalamic tumor, malformation, hydrocephalus and radiotheraphy. GnRH stimulation test is gold standard for diagnosis. GnRH agonists especially leuprorelin is very effective for treatment of idiopathic central precocious puberty. This case is presented because of vaginal bleeding is unusual cause of administration for this age.

Metrics

Metrics Loading ...

References

Merke DP, Cutler GB. Evaluation and management of precocious puberty. Arch Dis Child. 1996;75:269-271.

Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics. 1999;104:936-941.

Kalfa N, Ecochard A, Patte C, Duvillard P, Audran F, Peinkowski C, et al. Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J Clin Endocrinol Metab. 2006;91:1842-1847.

Lee PA. Advances in the management of precocious puberty. Clin Pediatr. 1994;54-61.

Carel JC, Lahlou N, Roger M, Chaussain JL. Precocious puberty and statural growth. Human Reproduction Update. 2004;10:135-147.

Mul D, Hughes IA. The use of GnRH agonists in precocious puberty. Eur Endocrin. 2008;159:3-8.

Neely EK, Wilson DM, Lee PA, Stene M, Hintz RL. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty. J Pediatr. 1995;127:47-52.

Kaplowitz PB. Treatment of central precocious puberty. Curr Opin Endocrinol Diabetes Obes. 2009;16:31-36.

Oerter KE, Uriarte MM, Rose SR, Barnes KM, Cutler GB. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrin Metab. 1990;71:1251-1258.

De Vries L, Horev G, Schwartz M, Phillip M. Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche. Eur J Endocrin. 2006;154:891-898.

Chalumeau M, Hadjiathanasiou CG, Ng SM. Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule. J Pediatr. 2003;143:445-450.

Sigurjonsdottir TJ, Hayles AB. Precocious puberty. A report of 96 cases. Am J Dis Child. 1968;115:309-321.

Tung YC, Lee JS, Tsai WY, Hsiao PH. The Effects of Gonadotropin Releasing Hormone Analogue Therapy on Girls with Gonadotropin-dependent Precocious Puberty. J Formos Med Assoc. 2007;106:826-831.

Partsch JC, Heger S, Sippell WG. Management and outcome of central precocious puberty. Clin Endocrin. 2002;56:129-148.

Cisternino M, Arrigo T, Pasquino AM. Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrin Metab. 2000;13:695-701.

Prete G, Couto-Silva AC, Trivin C, Brauner R. Idiopathic central precocious puberty in girls: presentation factors. BMC Pediatr. 2008;8:27-33.

Crowley WF, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrin Metab. 1981;52:370-372.

Lahlou N, Carel JC, Chaussain JL, Roger M. Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrin Metab. 2000;13:723-737.